Tocilizumab |
rhPM-1; RO-48775533; RG-1569; MRA; HPM-1; MRA-SC; R-1569 |
Approved |
Chugai Pharmaceutical Co Ltd |
Actemra, RoActemra, 雅美罗, Actemra/RoActemra, Acterma |
Japan |
Arthritis, Juvenile; Arthritis, Rheumatoid; Giant Cell Arteritis; Takayasu Arteritis; Cytokine Release Syndrome; Multicentric Castleman's Disease (MCD) |
null |
2005-04-11 |
Lymphoma; Graves Ophthalmopathy; Ascites; Takayasu Arteritis; Pancreatitis, Chronic; Coronavirus Infections; Pulmonary Arterial Hypertension; Coronary Disease; Lupus Erythematosus, Systemic; Breast Neoplasms; systemic sclerosis-associated interstitial lung disease; Multicentric Castleman's Disease (MCD); Fever; Uveitis, Posterior; Stroke; Pulmonary Disease, Chronic Obstructive; Osteoarthritis; Uveitis; Rejection in heart transplantation; Inflammation; Pleural Effusion, Malignant; Panuveitis; Diabetes Mellitus; Behcet Syndrome; Amyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Carcinoma, Hepatocellular; Non-ST Elevated Myocardial Infarction; Myocardial Infarction; Hematologic Neoplasms; Solid tumours; Cytokine Release Syndrome; Motor Neuron Disease; HIV Infections; Diabetes Mellitus, Type 1; Acute Chest Syndrome; Craniopharyngioma; Polymyositis; Giant Cell Arteritis; Schnitzler Syndrome; Depressive Disorder, Major; Polyarticular Juvenile Idiopathic Arthritis; Non-radiographic axial spondyloarthritis; Uveitis |
Details
|
Tocilizumab biosimilar (Bio-Thera Solutions) |
BAT-1806; BIIB-800 |
Approved |
Bio-Thera Solutions Ltd |
施瑞立, TOFIDENCE |
Mainland China |
Arthritis, Rheumatoid; Arthritis, Juvenile; Cytokine Release Syndrome |
Bio-Thera Solutions Ltd |
2023-01-16 |
Cytokine Release Syndrome; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Arthritis, Juvenile |
Details
|
Sarilumab |
SAR-153191; REGN-88 |
Approved |
Sanofi, Regeneron Pharmaceuticals Inc |
Kevzara |
United States |
Arthritis, Rheumatoid |
Sanofi-Synthelabo |
2017-05-22 |
Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Coronavirus Disease 2019 (COVID-19); Mastocytosis, Systemic; Sarcoidosis; Arthritis, Juvenile; Polymyalgia Rheumatica; Severe Acute Respiratory Syndrome; Uveitis |
Details
|
Tocilizumab biosimilar (Livzon Group) |
LZM-008 |
Approved |
Livzon Pharmaceutical Group Inc |
安维泰 |
Mainland China |
Arthritis, Rheumatoid |
Livzon Mabpharm Inc |
2023-01-18 |
Arthritis, Rheumatoid |
Details
|
Tocilizumab biosimilar (Fresenius kabi) |
MSB-11456; AT-220 (Arecor Therapeutics) |
Approved |
Merck Serono |
Tyenne |
EU |
Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Arthritis, Rheumatoid; Giant Cell Arteritis |
Fresenius Kabi Deutschland Gmbh |
2023-09-15 |
Cytokine Release Syndrome; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19) |
Details
|
Tocilizumab biosimilar (BioRay Pharm) |
|
Approved |
Hisun Biopharmaceutical Co Ltd |
|
Mainland China |
Arthritis, Rheumatoid |
Hisun Biopharmaceutical Co Ltd |
2024-06-25 |
Arthritis, Rheumatoid |
Details
|
Tocilizumab biosimilar (Celltrion) |
CT-P47; CT-P-47 |
Approved |
Celltrion Inc |
Avtozma |
United States |
Arthritis, Juvenile; Arthritis, Rheumatoid; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Coronavirus Disease 2019 (COVID-19) |
Celltrion Inc |
2025-01-24 |
Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Arthritis, Juvenile |
Details
|
Tocilizumab biosimilar (Maibo Taike) |
CMAB-806; CMAB806 |
Approved |
Taizhou Maibo Taike Biotechnology Co Ltd, Jinyu Bowo Runze Biotechnology Co Ltd |
|
Mainland China |
Arthritis, Rheumatoid |
Jinyu Bowo Runze Biotechnology Co Ltd |
2024-10-16 |
Arthritis, Rheumatoid; Arthritis |
Details
|